![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SRD5A1 |
Gene summary for SRD5A1 |
![]() |
Gene information | Species | Human | Gene symbol | SRD5A1 | Gene ID | 6715 |
Gene name | steroid 5 alpha-reductase 1 | |
Gene Alias | S5AR 1 | |
Cytomap | 5p15.31 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P18405 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6715 | SRD5A1 | LZE4T | Human | Esophagus | ESCC | 2.23e-06 | 1.56e-01 | 0.0811 |
6715 | SRD5A1 | LZE22T | Human | Esophagus | ESCC | 7.00e-06 | 4.33e-01 | 0.068 |
6715 | SRD5A1 | LZE24T | Human | Esophagus | ESCC | 7.10e-05 | 2.25e-01 | 0.0596 |
6715 | SRD5A1 | P1T-E | Human | Esophagus | ESCC | 4.94e-13 | 9.69e-01 | 0.0875 |
6715 | SRD5A1 | P2T-E | Human | Esophagus | ESCC | 7.08e-17 | 5.08e-01 | 0.1177 |
6715 | SRD5A1 | P4T-E | Human | Esophagus | ESCC | 1.83e-15 | 4.34e-01 | 0.1323 |
6715 | SRD5A1 | P5T-E | Human | Esophagus | ESCC | 3.80e-08 | 3.43e-01 | 0.1327 |
6715 | SRD5A1 | P8T-E | Human | Esophagus | ESCC | 2.47e-13 | 2.14e-01 | 0.0889 |
6715 | SRD5A1 | P9T-E | Human | Esophagus | ESCC | 1.14e-07 | 9.67e-02 | 0.1131 |
6715 | SRD5A1 | P10T-E | Human | Esophagus | ESCC | 6.61e-17 | 3.04e-01 | 0.116 |
6715 | SRD5A1 | P11T-E | Human | Esophagus | ESCC | 1.67e-08 | 3.35e-01 | 0.1426 |
6715 | SRD5A1 | P12T-E | Human | Esophagus | ESCC | 3.31e-10 | 3.60e-01 | 0.1122 |
6715 | SRD5A1 | P15T-E | Human | Esophagus | ESCC | 2.28e-07 | 1.14e-01 | 0.1149 |
6715 | SRD5A1 | P16T-E | Human | Esophagus | ESCC | 3.87e-16 | 2.60e-01 | 0.1153 |
6715 | SRD5A1 | P17T-E | Human | Esophagus | ESCC | 2.08e-10 | 6.32e-01 | 0.1278 |
6715 | SRD5A1 | P19T-E | Human | Esophagus | ESCC | 3.28e-02 | 4.93e-01 | 0.1662 |
6715 | SRD5A1 | P20T-E | Human | Esophagus | ESCC | 1.44e-54 | 1.36e+00 | 0.1124 |
6715 | SRD5A1 | P21T-E | Human | Esophagus | ESCC | 1.57e-13 | 4.17e-01 | 0.1617 |
6715 | SRD5A1 | P22T-E | Human | Esophagus | ESCC | 4.99e-11 | 2.52e-01 | 0.1236 |
6715 | SRD5A1 | P23T-E | Human | Esophagus | ESCC | 4.13e-18 | 6.28e-01 | 0.108 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000609119 | Oral cavity | LP | generation of precursor metabolites and energy | 214/4623 | 490/18723 | 1.12e-20 | 2.60e-18 | 214 |
GO:190136116 | Oral cavity | LP | organic cyclic compound catabolic process | 180/4623 | 495/18723 | 3.11e-09 | 1.35e-07 | 180 |
GO:0071496110 | Oral cavity | LP | cellular response to external stimulus | 124/4623 | 320/18723 | 1.44e-08 | 5.36e-07 | 124 |
GO:0031667110 | Oral cavity | LP | response to nutrient levels | 165/4623 | 474/18723 | 3.87e-07 | 1.12e-05 | 165 |
GO:1901654110 | Oral cavity | LP | response to ketone | 78/4623 | 194/18723 | 1.24e-06 | 3.03e-05 | 78 |
GO:0048545110 | Oral cavity | LP | response to steroid hormone | 122/4623 | 339/18723 | 1.91e-06 | 4.39e-05 | 122 |
GO:000188919 | Oral cavity | LP | liver development | 62/4623 | 147/18723 | 2.32e-06 | 5.14e-05 | 62 |
GO:0048732110 | Oral cavity | LP | gland development | 149/4623 | 436/18723 | 4.51e-06 | 9.17e-05 | 149 |
GO:006100819 | Oral cavity | LP | hepaticobiliary system development | 62/4623 | 150/18723 | 5.13e-06 | 1.03e-04 | 62 |
GO:0031668110 | Oral cavity | LP | cellular response to extracellular stimulus | 91/4623 | 246/18723 | 1.07e-05 | 1.94e-04 | 91 |
GO:0043434110 | Oral cavity | LP | response to peptide hormone | 138/4623 | 414/18723 | 4.00e-05 | 5.87e-04 | 138 |
GO:190165317 | Oral cavity | LP | cellular response to peptide | 122/4623 | 359/18723 | 4.22e-05 | 6.10e-04 | 122 |
GO:003166919 | Oral cavity | LP | cellular response to nutrient levels | 79/4623 | 215/18723 | 5.16e-05 | 7.21e-04 | 79 |
GO:000926718 | Oral cavity | LP | cellular response to starvation | 59/4623 | 156/18723 | 1.78e-04 | 1.99e-03 | 59 |
GO:004259417 | Oral cavity | LP | response to starvation | 71/4623 | 197/18723 | 2.36e-04 | 2.52e-03 | 71 |
GO:007138319 | Oral cavity | LP | cellular response to steroid hormone stimulus | 71/4623 | 204/18723 | 7.42e-04 | 6.62e-03 | 71 |
GO:003196019 | Oral cavity | LP | response to corticosteroid | 60/4623 | 167/18723 | 7.51e-04 | 6.69e-03 | 60 |
GO:003235516 | Oral cavity | LP | response to estradiol | 52/4623 | 141/18723 | 8.28e-04 | 7.24e-03 | 52 |
GO:005138419 | Oral cavity | LP | response to glucocorticoid | 54/4623 | 148/18723 | 8.90e-04 | 7.64e-03 | 54 |
GO:003286817 | Oral cavity | LP | response to insulin | 88/4623 | 264/18723 | 9.19e-04 | 7.82e-03 | 88 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SRD5A1 | SNV | Missense_Mutation | c.460N>C | p.Gly154Arg | p.G154R | P18405 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SRD5A1 | SNV | Missense_Mutation | c.688N>C | p.Ser230Pro | p.S230P | P18405 | protein_coding | tolerated(0.2) | benign(0.145) | TCGA-BH-A0DG-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
SRD5A1 | SNV | Missense_Mutation | novel | c.408N>A | p.Ser136Arg | p.S136R | P18405 | protein_coding | deleterious(0.01) | possibly_damaging(0.463) | TCGA-AA-3869-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | capecitabine | PD |
SRD5A1 | SNV | Missense_Mutation | c.353C>T | p.Thr118Ile | p.T118I | P18405 | protein_coding | tolerated(0.29) | benign(0) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD | |
SRD5A1 | SNV | Missense_Mutation | c.613N>A | p.Glu205Lys | p.E205K | P18405 | protein_coding | deleterious(0.02) | possibly_damaging(0.856) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SRD5A1 | SNV | Missense_Mutation | novel | c.721N>T | p.Leu241Phe | p.L241F | P18405 | protein_coding | deleterious(0.02) | probably_damaging(0.917) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SRD5A1 | SNV | Missense_Mutation | c.758N>G | p.Ile253Ser | p.I253S | P18405 | protein_coding | tolerated(0.22) | benign(0.065) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SRD5A1 | SNV | Missense_Mutation | rs374499334 | c.674N>T | p.Thr225Met | p.T225M | P18405 | protein_coding | deleterious(0) | possibly_damaging(0.883) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SRD5A1 | SNV | Missense_Mutation | novel | c.759N>G | p.Ile253Met | p.I253M | P18405 | protein_coding | tolerated(0.06) | benign(0.222) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SRD5A1 | SNV | Missense_Mutation | novel | c.286G>T | p.Gly96Trp | p.G96W | P18405 | protein_coding | deleterious(0.03) | benign(0.014) | TCGA-05-4396-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6715 | SRD5A1 | DRUGGABLE GENOME | LEVONORGESTREL | LEVONORGESTREL | ||
6715 | SRD5A1 | DRUGGABLE GENOME | DUTASTERIDE | DUTASTERIDE | ||
6715 | SRD5A1 | DRUGGABLE GENOME | BEXLOSTERIDE | BEXLOSTERIDE | ||
6715 | SRD5A1 | DRUGGABLE GENOME | FR-146687 | |||
6715 | SRD5A1 | DRUGGABLE GENOME | FINASTERIDE | FINASTERIDE | ||
6715 | SRD5A1 | DRUGGABLE GENOME | LY-266111 | CHEMBL29166 | ||
6715 | SRD5A1 | DRUGGABLE GENOME | FINASTERIDE | FINASTERIDE | ||
6715 | SRD5A1 | DRUGGABLE GENOME | DUTASTERIDE | DUTASTERIDE | ||
6715 | SRD5A1 | DRUGGABLE GENOME | inhibitor | CHEMBL1200969 | DUTASTERIDE |
Page: 1 |